/PRNewswire/ - Today, Symetryx Corporation ("Symetryx") announces that it has reviewed the filings between CHECK-CAP Ltd. ("Check-Cap") and Keystone Dental.
Gainers PhenomeX Inc. (NASDAQ: CELL) shares surged 138.3% to $0.9532. Bruker Corporation and PhenomeX reported a $108 million definitive agreement for Bruker to acquire PhenomeX in an all-cash transaction for $1 per share.
By Will Feuer Check-Cap has agreed to merge with Keystone Dental Holdings in a roughly $265 million deal that would see Keystone take the place of Check-Cap.
Proposed business combination to create a Nasdaq-listed medical device company focused on advancing the commercial execution and market development of.